Pentoxifylline alleviates cardiac ischemia and dysfunction following experimental angina in insulin resistance

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Azhar, Ahmad ^a   El Bassossy, Hany M ^b,c  

^a King Abdulaziz University   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c Zagazig University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PENTOXIFYLLINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; ISOPRENALINE; LIPID; PROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; RAT; ST SEGMENT DEPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; DIET; DISEASE MODEL; DRUG EFFECTS; ELECTROCARDIOGRAPHY; HEART CONTRACTION; INFLAMMATION; METABOLISM; MYOCARDIAL ISCHEMIA; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPONECTIN; ADMINISTRATION, ORAL; ANGINA PECTORIS; ANIMALS; DIET; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; INFLAMMATION; INSULIN RESISTANCE; ISOPROTERENOL; LIPIDS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; PENTOXIFYLLINE; PROTECTIVE AGENTS; RATS; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 84902187978     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098281     Document Type: Article

References (29)

1. Raskin P (2010) Risk factors for the development of diabetic complications. Journal of Diabetes and its Complications 8: 195-200. DOI: 10.1016/1056-8727(94)90043-4.
2. DeFronzo RA, Del Prato S (2009) Insulin resistance and diabetes mellitus. Journal of Diabetes and its Complications 10: 243-245. DOI: 10.1016/1056-8727(96)00046-3.
3. Busija DW, Miller AW, Katakam P, Erdos B (2006) Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance. Antioxid Redox Signal 8: 1131-1140. (Pubitemid 44182413)
4. Marks JB, Raskin P (2003) Cardiovascular risk in diabetes: A brief review. Journal of Diabetes and its Complications 14: 108-115. DOI: 10.1016/S1056-8727(00)00065-9.
5. Dhurandhar RW, Watt DL, Silver MD, Trimble AS, Adelman AG (1972) Prinzmetal's variant form of angina with arteriographic evidence of coronary arterial spasm. The American Journal of Cardiology 30: 902-905.
6. Yasue H, Omote S, Takizawa A, Nagao M (1983) Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circulation Research 52: I.
7. Soliman EZ, Prineas RJ, Case LD, Russell G, Rosamond W, et al (2011) Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease. Heart 97: 1597-1601.
8. Chen H (2006) Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol Res 53: 469-477.
9. Shaw SM, Shah MKH, Williams SG, Fildes JE (2009) Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 11: 113-118.
10. Seiffge D, Kremer E (1984) Antithrombotic effects of pentoxifylline on laser-induced thrombi in rat mesenteric arteries. IRCS Medical Science 12: 91-92. (Pubitemid 14154862)
11. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, et al (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: F625-F631. (Pubitemid 43724964)
12. Field KJ, White WJ, Lang CM (1993) Anaesthetic effects of chloral hydrate, pentobarbitone and urethane in adult male rats. Laboratory Animals 27: 258-269. (Pubitemid 23222285)
13. Yamamoto S, Matsui K, Sasabe M, Kitano M, Ohashi N (2000) Effect of SMP-300, a new Na+/H+ exchange inhibitor, on myocardial ischemia and experimental angina models in rats. Jpn J Pharmacol 84: 196-205.
14. Radovits T, Bomicke T, Kokeny G, Arif R, Loganathan S, et al G (2009) The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus. Br J Pharmacol 156: 909-919.
15. Mori T, Ishigai Y, Fukuzawa A, Chiba K, Shibano T (1995) Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model. Br J Pharmacol 116: 1668-1672.
16. Williams IL, Vazir A, Zaman AG (2003) Review: The management of stable angina in diabetes. The British Journal of Diabetes & Vascular Disease 3: 18-25. (Pubitemid 37051482)
17. Zhang M, LXY, Zhang HY, Wang CM, Chen L (2008) The protective effect of pentoxifylline on myocardium injury induced by ischemia-reperfusion and Ca2+ paradox. Chin Pharmacol Bull 24: 937-941.
18. Maslov LN, Lasukova OV, Krylatov AV, Hanus LO, Pertwee R, et al (2006) Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion. Bull Exp Biol Med 142: 557-561. (Pubitemid 46499120)
19. Osadchii O, Norton G, Woodiwiss A (2005) Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats. Eur J Pharmacol 514: 201-208. (Pubitemid 40720361)
20. Robinson DA, Wang P, Chaudry IH (1996) Pentoxifylline restores the depressed cardiac performance after trauma- hemorrhage and resuscitation. J SURG RES 66: 51-56. (Pubitemid 27009375)
21. SchÌfer S, Huber J, Wihler C, Rtten H, Busch AE, et al (2006) Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N-(carboxymethyl)lysine. Eur J Heart Fail 8: 2-6.
22. Loganathan R, Bilgen M, Al-Hafez B, Alenezy MD, Smirnova IV (2006) Cardiac dysfunction in the diabetic rat: Quantitative evaluation using high resolution magnetic resonance imaging. Cardiovasc Diabetol 4; 5:7.
23. Radovits T, Korkmaz S, Loganathan S, Barnucz E, B micke T, et al (2009) Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol - Heart Circ Physiol 297: H125-H133.
24. Zhang M, L XY, Zhang HY, Wang CM, Chen L (2008) The protective effect of pentoxifylline on myocardium injury induced by ischemia-reperfusion and Ca2+ paradox. Chin Pharmacol Bull 24: 937-941.
25. Pickup JC (2004) Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes. Diabetes Care 27: 813-823.
26. El-Bassossy HM, El-Moselhy MA, Mahmoud MF (2011) Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Naunyn Schmiedebergs Arch Pharmacol 384: 277-285.
27. Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A (2013) Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation. PLoS ONE 8(5):e63784.
28. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295. (Pubitemid 35373562)
29. Miller RA, Chu Q, Le Lay J, Scherer PE, Ahima RS, Kaestner KH, Foretz M, Viollet B, Birnbaum MJ (2011) Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J Clin Invest 121: 2518-2528.